These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 32708735)
1. DNA Methylation Dysfunction in Chronic Kidney Disease. Ingrosso D; Perna AF Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32708735 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology. Morgado-Pascual JL; Marchant V; Rodrigues-Diez R; Dolade N; Suarez-Alvarez B; Kerr B; Valdivielso JM; Ruiz-Ortega M; Rayego-Mateos S Mediators Inflamm; 2018; 2018():2931049. PubMed ID: 30647531 [TBL] [Abstract][Full Text] [Related]
3. Vitamin B Supplementation and Nutritional Intake of Methyl Donors in Patients with Chronic Kidney Disease: A Critical Review of the Impact on Epigenetic Machinery. Cappuccilli M; Bergamini C; Giacomelli FA; Cianciolo G; Donati G; Conte D; Natali T; La Manna G; Capelli I Nutrients; 2020 Apr; 12(5):. PubMed ID: 32349312 [TBL] [Abstract][Full Text] [Related]
13. Transcription factors and epigenetic modulation: its therapeutic implication in chronic kidney disease. Hayashi K; Itoh H Arch Immunol Ther Exp (Warsz); 2015 Jun; 63(3):193-6. PubMed ID: 25503375 [TBL] [Abstract][Full Text] [Related]
14. Progression and outcomes of non-dialysis dependent chronic kidney disease patients: A single center longitudinal follow-up study. Khan YH; Sarriff A; Adnan AS; Khan AH; Mallhi TH; Jummaat F Nephrology (Carlton); 2017 Jan; 22(1):25-34. PubMed ID: 26718476 [TBL] [Abstract][Full Text] [Related]
15. DNA methylation and the potential role of demethylating agents in prevention of progressive chronic kidney disease. Larkin BP; Glastras SJ; Chen H; Pollock CA; Saad S FASEB J; 2018 Oct; 32(10):5215-5226. PubMed ID: 29688808 [TBL] [Abstract][Full Text] [Related]
16. The Fukuoka Kidney disease Registry (FKR) Study: design and methods. Tanaka S; Ninomiya T; Fujisaki K; Yoshida H; Nagata M; Masutani K; Tokumoto M; Mitsuiki K; Hirakata H; Fujimi S; Kiyohara Y; Kitazono T; Tsuruya K; Clin Exp Nephrol; 2017 Jun; 21(3):465-473. PubMed ID: 27339444 [TBL] [Abstract][Full Text] [Related]
17. A population-based cohort study defines prognoses in severe chronic kidney disease. Tonelli M; Wiebe N; James MT; Klarenbach SW; Manns BJ; Ravani P; Strippoli GFM; Hemmelgarn BR; Kidney Int; 2018 May; 93(5):1217-1226. PubMed ID: 29525394 [TBL] [Abstract][Full Text] [Related]
18. Current drug development challenges in chronic kidney disease (CKD)--identification of individualized determinants of renal progression and premature cardiovascular disease (CVD). Formentini I; Bobadilla M; Haefliger C; Hartmann G; Loghman-Adham M; Mizrahi J; Pomposiello S; Prunotto M; Meier M Nephrol Dial Transplant; 2012 Oct; 27 Suppl 3():iii81-8. PubMed ID: 22734108 [TBL] [Abstract][Full Text] [Related]
19. Assessment of matrix Gla protein, Klotho gene polymorphisms, and oxidative stress in chronic kidney disease. Karsli Ceppioğlu S; Yurdun T; Canbakan M Ren Fail; 2011; 33(9):866-74. PubMed ID: 21859400 [TBL] [Abstract][Full Text] [Related]
20. Left ventricular hypertrophy and progression of chronic kidney disease. Paoletti E J Nephrol; 2012; 25(6):847-50. PubMed ID: 22460180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]